O	0	7	Natural
O	8	15	history
O	16	18	of
B-Symptom	19	25	drusen
O	26	36	morphology
O	37	39	in
B-Disease	40	43	age
I-Disease	43	44	-
I-Disease	44	51	related
I-Disease	52	59	macular
I-Disease	60	72	degeneration
O	73	78	using
B-Diagnostic_tool	79	87	spectral
I-Diagnostic_tool	88	94	domain
I-Diagnostic_tool	95	102	optical
I-Diagnostic_tool	103	112	coherence
I-Diagnostic_tool	113	123	tomography
O	123	124	.

O	126	128	To
O	129	141	characterize
O	142	145	the
O	146	153	natural
O	154	161	history
O	162	164	of
B-Symptom	165	171	drusen
O	172	177	using
B-Diagnostic_tool	178	186	spectral
I-Diagnostic_tool	186	187	-
I-Diagnostic_tool	187	193	domain
I-Diagnostic_tool	194	201	optical
I-Diagnostic_tool	202	211	coherence
I-Diagnostic_tool	212	222	tomography
I-Diagnostic_tool	223	224	(
I-Diagnostic_tool	224	226	SD
I-Diagnostic_tool	226	227	-
I-Diagnostic_tool	227	230	OCT
I-Diagnostic_tool	230	231	)
I-Diagnostic_tool	232	239	imaging
O	240	242	of
B-Anatomy	243	247	eyes
O	248	252	from
O	253	261	patients
O	262	266	with
B-Disease	267	279	nonexudative
I-Disease	280	283	age
I-Disease	283	284	-
I-Disease	284	291	related
I-Disease	292	299	macular
I-Disease	300	312	degeneration
O	313	314	(
B-Disease	314	317	AMD
O	317	318	)
O	318	319	.

O	320	331	Prospective
O	331	332	,
O	333	345	longitudinal
O	345	346	,
O	347	354	natural
O	355	362	history
O	363	368	study
O	368	369	.

O	370	372	We
O	373	381	included
O	382	385	143
B-Anatomy	386	390	eyes
O	391	393	of
O	394	397	100
O	398	406	patients
O	407	411	with
O	412	414	at
O	415	420	least
O	421	422	6
O	423	429	months
O	430	432	of
O	433	439	follow
O	439	440	-
O	440	442	up
O	442	443	.

O	444	452	Patients
O	453	457	with
B-Symptom	458	464	drusen
O	465	474	secondary
O	475	477	to
B-Disease	478	490	nonexudative
I-Disease	491	494	AMD
O	495	499	were
O	500	507	scanned
O	508	513	using
O	514	517	the
B-Diagnostic_tool	518	524	Cirrus
I-Diagnostic_tool	525	527	SD
I-Diagnostic_tool	527	528	-
I-Diagnostic_tool	528	531	OCT
O	532	542	instrument
O	542	543	.

B-Anatomy	544	548	Eyes
O	549	553	were
O	554	560	imaged
O	561	566	using
O	567	570	the
O	571	574	200
O	575	576	×
O	577	580	200
O	581	582	A
O	582	583	-
O	583	587	scan
O	588	594	raster
O	595	602	pattern
O	603	612	contained
O	613	619	within
O	620	621	a
O	622	623	6
O	624	625	×
O	626	627	6
O	628	630	mm
O	631	635	area
O	635	636	.

O	637	643	Custom
O	644	652	software
O	653	656	was
O	657	661	used
O	662	664	to
O	665	673	quantify
O	674	684	volumetric
O	685	692	changes
O	693	695	in
B-Symptom	696	702	drusen
O	703	707	over
O	708	709	a
O	710	716	period
O	717	719	of
O	720	721	≥
O	722	723	6
O	724	730	months
O	731	734	and
O	735	738	for
O	739	741	as
O	742	746	long
O	747	749	as
O	750	752	24
O	753	759	months
O	759	760	.

B-Characteristic	761	767	Drusen
I-Characteristic	768	774	volume
O	775	778	and
B-Characteristic	779	785	drusen
I-Characteristic	786	790	area
O	791	795	were
O	796	804	measured
O	805	811	within
O	812	820	circular
O	821	828	regions
O	829	837	centered
O	838	840	at
O	841	844	the
B-Anatomy	845	850	fovea
O	851	857	having
O	858	867	diameters
O	868	870	of
O	871	872	3
O	873	876	and
O	877	878	5
O	879	881	mm
O	881	882	.

O	883	886	The
O	887	899	measurements
O	900	904	were
O	905	913	analyzed
O	914	919	using
O	920	921	a
O	922	930	suitable
O	931	936	scale
O	937	951	transformation
O	951	952	.

O	953	956	For
B-Characteristic	957	963	drusen
I-Characteristic	964	970	volume
O	970	971	,
O	972	973	a
O	974	978	cube
O	979	983	root
O	984	998	transformation
O	999	1007	strategy
O	1008	1011	was
O	1012	1016	used
O	1016	1017	.

O	1018	1024	Change
O	1025	1027	in
B-Characteristic	1028	1034	drusen
I-Characteristic	1035	1041	volume
O	1042	1045	and
O	1046	1050	area
O	1051	1055	over
O	1056	1060	time
O	1060	1061	.

O	1062	1064	We
O	1065	1073	analyzed
O	1074	1077	143
B-Anatomy	1078	1082	eyes
O	1083	1085	of
O	1086	1089	100
O	1090	1098	patients
O	1099	1103	with
O	1104	1106	69
B-Anatomy	1107	1111	eyes
O	1112	1120	followed
O	1121	1124	for
O	1125	1126	6
O	1127	1133	months
O	1133	1134	,
O	1135	1138	106
B-Anatomy	1139	1143	eyes
O	1144	1152	followed
O	1153	1156	for
O	1157	1159	12
O	1160	1166	months
O	1166	1167	,
O	1168	1170	48
B-Anatomy	1171	1175	eyes
O	1176	1184	followed
O	1185	1188	for
O	1189	1191	18
O	1192	1198	months
O	1198	1199	,
O	1200	1203	and
O	1204	1206	48
B-Anatomy	1207	1211	eyes
O	1212	1220	followed
O	1221	1224	for
O	1225	1227	24
O	1228	1234	months
O	1234	1235	.

O	1236	1239	The
O	1240	1241	3
O	1242	1244	mm
O	1245	1251	circle
O	1252	1260	baseline
B-Characteristic	1261	1267	drusen
I-Characteristic	1268	1274	volume
O	1275	1281	ranged
O	1282	1286	from
B-Dimension	1287	1288	0
I-Dimension	1288	1289	.
I-Dimension	1289	1293	0009
I-Dimension	1294	1296	to
I-Dimension	1297	1298	0
I-Dimension	1298	1299	.
I-Dimension	1299	1303	7479
I-Dimension	1304	1306	mm
I-Dimension	1306	1307	(
I-Dimension	1307	1308	3
I-Dimension	1308	1309	)
O	1310	1312	or
B-Dimension	1313	1314	0
I-Dimension	1314	1315	.
I-Dimension	1315	1317	10
I-Dimension	1318	1320	to
I-Dimension	1321	1322	0
I-Dimension	1322	1323	.
I-Dimension	1323	1325	91
I-Dimension	1326	1328	mm
O	1329	1334	using
O	1335	1338	the
O	1339	1343	cube
O	1344	1348	root
O	1349	1354	scale
O	1354	1355	.

O	1356	1358	On
O	1359	1366	average
O	1366	1367	,
B-Characteristic	1368	1374	drusen
I-Characteristic	1375	1381	volume
O	1382	1385	and
B-Characteristic	1386	1392	drusen
I-Characteristic	1393	1397	area
O	1398	1407	increased
O	1408	1412	over
O	1413	1417	time
O	1418	1422	with
O	1423	1426	the
O	1427	1436	magnitude
O	1437	1439	of
O	1440	1443	the
O	1444	1452	increase
O	1453	1462	dependent
O	1463	1465	on
O	1466	1469	the
O	1470	1476	length
O	1477	1479	of
O	1480	1486	follow
O	1486	1487	-
O	1487	1489	up
O	1490	1491	(
O	1491	1492	P
O	1493	1494	=
O	1495	1496	0
O	1496	1497	.
O	1497	1500	001
O	1500	1501	,
O	1502	1503	3
O	1504	1506	mm
O	1507	1513	circle
O	1513	1514	)
O	1514	1515	.

O	1516	1518	In
O	1519	1522	the
B-Anatomy	1523	1527	eyes
O	1528	1532	with
O	1533	1534	a
O	1535	1543	decrease
O	1544	1546	in
B-Characteristic	1547	1553	drusen
I-Characteristic	1554	1560	volume
O	1560	1561	,
O	1562	1565	the
O	1566	1575	magnitude
O	1576	1578	of
O	1579	1583	this
O	1584	1592	decrease
O	1593	1596	was
O	1597	1606	dependent
O	1607	1609	on
O	1610	1613	the
O	1614	1622	baseline
B-Characteristic	1623	1629	drusen
I-Characteristic	1630	1636	volume
O	1637	1638	(
O	1638	1639	P
O	1640	1641	=
O	1642	1643	0
O	1643	1644	.
O	1644	1647	001
O	1647	1648	,
O	1649	1650	3
O	1651	1653	mm
O	1654	1660	circle
O	1660	1661	)
O	1662	1665	and
O	1666	1677	independent
O	1678	1680	of
O	1681	1684	the
O	1685	1691	follow
O	1691	1692	-
O	1692	1694	up
O	1695	1703	interval
O	1703	1704	.

O	1705	1710	After
O	1711	1713	12
O	1714	1720	months
O	1720	1721	,
B-Characteristic	1722	1728	drusen
I-Characteristic	1729	1735	volume
O	1736	1745	increased
O	1746	1748	in
O	1749	1751	48
O	1751	1752	%
O	1753	1755	of
B-Anatomy	1756	1760	eyes
O	1760	1761	,
O	1762	1770	remained
O	1771	1777	stable
O	1778	1780	in
O	1781	1783	40
O	1783	1784	%
O	1784	1785	,
O	1786	1789	and
O	1790	1799	decreased
O	1800	1802	in
O	1803	1805	12
O	1805	1806	%
O	1806	1807	.

B-Diagnostic_tool	1808	1815	Imaging
I-Diagnostic_tool	1816	1820	with
I-Diagnostic_tool	1821	1823	SD
I-Diagnostic_tool	1823	1824	-
I-Diagnostic_tool	1824	1827	OCT
O	1828	1836	revealed
O	1837	1838	a
O	1839	1846	dynamic
O	1846	1847	,
O	1848	1858	undulating
O	1859	1865	growth
O	1866	1873	pattern
O	1874	1877	for
B-Symptom	1878	1884	drusen
O	1885	1889	with
O	1890	1891	a
O	1892	1900	tendency
O	1901	1904	for
B-Symptom	1905	1911	drusen
O	1912	1914	to
O	1915	1923	increase
O	1924	1926	in
O	1927	1933	volume
O	1934	1937	and
O	1938	1942	area
O	1943	1947	over
O	1948	1952	time
O	1952	1953	.

O	1954	1956	An
O	1957	1969	appreciation
O	1970	1972	of
O	1973	1976	the
O	1977	1989	quantitative
O	1990	1997	changes
O	1998	2000	in
B-Characteristic	2001	2007	drusen
I-Characteristic	2008	2014	volume
O	2015	2019	over
O	2020	2024	time
O	2025	2030	using
B-Diagnostic_tool	2031	2033	SD
I-Diagnostic_tool	2033	2034	-
I-Diagnostic_tool	2034	2037	OCT
I-Diagnostic_tool	2038	2045	imaging
O	2046	2054	provides
O	2055	2056	a
O	2057	2062	novel
O	2063	2071	strategy
O	2072	2075	for
O	2076	2085	following
O	2086	2092	normal
O	2093	2100	disease
O	2101	2112	progression
O	2113	2116	and
O	2117	2120	for
O	2121	2132	identifying
O	2133	2138	novel
O	2139	2147	clinical
O	2148	2153	trial
O	2154	2157	end
O	2158	2164	points
O	2165	2167	to
O	2168	2170	be
O	2171	2175	used
O	2176	2180	when
O	2181	2194	investigating
O	2195	2204	therapies
O	2205	2208	for
O	2209	2212	the
O	2213	2222	treatment
O	2223	2225	of
B-Disease	2226	2238	nonexudative
I-Disease	2239	2242	AMD
O	2242	2243	.

O	2244	2255	Proprietary
O	2256	2258	or
O	2259	2269	commercial
O	2270	2280	disclosure
O	2281	2284	may
O	2285	2287	be
O	2288	2293	found
O	2294	2299	after
O	2300	2303	the
O	2304	2314	references
O	2314	2315	.
